Regulacje i polityka gospodarcza · 24/09/2020

Petragen, Inc. to Receive Exclusive Patent Commercialization License for Periodontal Disease Treatment

The National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent commercialization license to Petragen, Inc., a Delaware-based start-up, to use a patented method for treating periodontal disease.